Trump's New Health Aid Strategy Could Give US Access to Foreign Countries' Medical Data

The Trump administration is introducing controversial conditions for countries seeking American healthcare assistance, including requests to access national health data systems and pathogen samples that could help identify potentially deadly disease outbreaks.
The changes form part of the America First Global Health Strategy, which aims to reshape how the United States distributes billions of dollars in international health assistance. However, the approach has prompted concerns about patient privacy, national sovereignty and whether poorer countries could lose control over valuable medical information.
A 16 November investigation by The New York Times revealed that several governments have expressed discomfort with the conditions, with some reportedly feeling pressured to accept terms they would otherwise reject.
How Trump's Global Health Strategy Is Changing Foreign Aid
President Donald Trump announced the United States' withdrawal from the World Health Organisation (WHO) and paused foreign assistance shortly after returning to office in January 2025.
The subsequent dismantling of parts of the US Agency for International Development (USAID) disrupted healthcare programmes in several countries. Hospitals reported shortages of tuberculosis, malaria and HIV medicines, while clinics closed and patients participating in medical trials were left without continued support.
Congress had originally allocated approximately $10 billion to the government's major global health programmes, equivalent to around $30 per American resident. Despite widespread funding disruptions, lawmakers maintained that the money should still be spent.
The State Department subsequently introduced the America First Global Health Strategy in September 2025, encouraging recipient countries to assume greater responsibility for financing and managing their healthcare systems.
Some agreements also introduced conditions requiring recipient countries to share pathogen samples and related outbreak data, while others provide for US access to national health data systems.
Why the US Wants Access to Foreign Medical Data
Access to health information and pathogen samples could help American researchers identify emerging infectious diseases, monitor outbreaks and develop vaccines or treatments.
However, critics argue that the agreements could expose sensitive national health information to foreign governments and private contractors.
The concerns are particularly significant in countries where healthcare records contain information about millions of people living with HIV and other infectious diseases.
Kenya became the first country to sign an America First health agreement on 4 December 2025. The deal faced legal challenges over patient-data sharing and its constitutionality, prompting the High Court to suspend its implementation. However, on 13 October 2026, the Court of Appeal lifted the orders blocking the agreement, allowing it to proceed while the legal challenge remains unresolved.
The State Department has said that some data requests are intended for programme monitoring. However, critics argue that provisions in several agreements could give US entities broader access to sensitive health information, including outbreak data and national health databases.
Countries Push Back Against New Healthcare Conditions
The proposed arrangements have not received universal acceptance.
According to The New York Times investigation, the United States initially sought agreements with 71 recipient countries but had secured commitments from just 14 by December 2025. The number subsequently increased to 36 by 8 October 2026, according to KFF. Ghana, Namibia and Zimbabwe have publicly rejected proposed US health agreements.
Zambia objected to provisions requiring the sharing of patient data and biological specimens. Both were removed from the revised agreement signed on 8 October 2026.
The negotiations have also raised questions about whether healthcare assistance is being used to secure wider economic and political concessions. In several instances, discussions about health funding coincided with separate negotiations involving strategic minerals and the acceptance of deportees.
US officials have maintained that the negotiations are unrelated.
Could the Changes Affect Global Disease Prevention?
The controversy comes as international cooperation remains essential for identifying and containing infectious diseases before they spread across borders.
Sharing pathogen samples can help scientists investigate unfamiliar viruses and bacteria, understand how infections spread and develop medical countermeasures.
However, countries providing biological samples and health information also expect equitable access to medicines and vaccines developed using those resources.
The restructuring could therefore influence how governments cooperate during future outbreaks, particularly if concerns about data ownership and access discourage countries from sharing critical information.
The administration's strategy also encourages recipient governments to increase domestic healthcare spending, potentially reducing long-term dependence on foreign assistance.
However, countries with limited financial resources could struggle to replace American funding quickly enough to maintain essential programmes.
Although US global health assistance has not disappeared, its changing conditions could reshape international healthcare cooperation and influence how effectively countries respond to future public health emergencies.